Molecular, Cellular, and Integrative Biosciences Graduate Program, Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA 16802, USA.
Department of Biomedical Engineering, Pennsylvania State University, University Park, PA 16802, USA.
Int J Mol Sci. 2022 Dec 3;23(23):15267. doi: 10.3390/ijms232315267.
Mutations in tumor suppressor genes often lead to cancerous phenotypes. Current treatments leverage signaling pathways that are often compromised by disease-derived deficiencies in tumor suppressors. P53 falls into this category as genetic mutations lead to physical changes in the protein that impact multiple cellular pathways. Here, we show the first complete structural models of mutated p53 to reveal how hotspot mutations physically deviate from the wild-type protein. We employed a recently determined structure for the p53 monomer to map seven frequent clinical mutations using computational modeling approaches. Results showed that missense mutations often changed the conformational structure of p53 in the DNA-binding site along with its electrostatic surface charges. We posit these changes may amplify the toxic effects of these hotspot mutations by destabilizing an important zinc ion coordination region in p53 to impede proper DNA interactions. These results highlight the imperative need for new studies on patient-derived proteins that may assist in redesigning structure-informed targeted therapies.
肿瘤抑制基因的突变通常会导致癌症表型。目前的治疗方法利用了信号通路,而这些信号通路经常因肿瘤抑制因子的疾病衍生缺陷而受到影响。p53 属于这一类,因为基因突变导致蛋白质发生物理变化,从而影响多个细胞通路。在这里,我们展示了第一个突变 p53 的完整结构模型,以揭示热点突变如何在物理上偏离野生型蛋白。我们利用最近确定的 p53 单体结构,使用计算建模方法对七种常见的临床突变进行了映射。结果表明,错义突变通常会改变 DNA 结合位点中 p53 的构象结构及其静电表面电荷。我们假设这些变化可能通过破坏 p53 中一个重要的锌离子配位区域来阻碍适当的 DNA 相互作用,从而放大这些热点突变的毒性效应。这些结果强调了对可能有助于重新设计基于结构的靶向治疗的患者衍生蛋白进行新研究的必要性。